CNET on MSN21h
Novavax Is Here for the COVID Fight: What to Know About the Vaccine
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...
Novavax cools after clarifying analyst report on COVID vaccine market
Novavax (NVAX) stock fell after a clarification on an analyst report led to a sharp rally in the company stock in the ...
CNET5d
Make Room, mRNA: What to Know About the Novavax COVID Vaccine
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season ...
Is one COVID vaccine better than the others? An infectious disease doctor breaks it down
Which COVID vaccine is better of the Pfizer, Modern and Novavax options? Here's how they compare with safety and efficacy and ...
The Canadian Press on MSN2d
‘I have no options’: Canadians criticize lack of Novavax COVID shot
The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say.
Canada not ordering Novavax protein-based COVID vaccine this year due to low demand
TORONTO — The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus ...
The Canadian Press on MSN4d
Canada won’t be ordering Novavax’s updated COVID-19 vaccine, cites low demand
The Public Health Agency of Canada says a very small portion of the doses ordered in 2023 were used and that its decision reflects efforts to limit vaccine wastage.
Novavax: Lack Of Sustainable Revenue Growth Is A Problem
Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi. Find out why I remain ...